Menu
Back to User profile » Dr Yoshiyuki Morishita
Papers published by Dr Yoshiyuki Morishita:
The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis
Yanai K, Hirai K, Kaneko S, Mutsuyoshi Y, Kitano T, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Drug Design, Development and Therapy 2023, 17:3233-3248
Published Date: 3 November 2023
Clinical Factors Associated with Serum Magnesium Concentration in Patients Undergoing Peritoneal Dialysis: A Single-Center Observational Study
Kaneko S, Ookawara S, Morishita Y
International Journal of Nephrology and Renovascular Disease 2022, 15:185-195
Published Date: 24 May 2022
No Significant Changes of Glycemic Control and Renal Function in Patients with Advanced-Stage Diabetic Kidney Disease by Switching from Linagliptin to Teneligliptin
Hirai K, Nonaka H, Ueda M, Morino J, Kaneko S, Minato S, Mutsuyoshi Y, Yanai K, Ishii H, Matsuyama M, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Pragmatic and Observational Research 2021, 12:81-91
Published Date: 6 August 2021
Factors Associated with the Change in Carotid Maximum Intima-Media Thickness in Patients with Moderate-to-Advanced Stage Chronic Kidney Disease
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity 2020, 13:3637-3643
Published Date: 12 October 2020
The Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Advanced-Stage Diabetic Kidney Disease Taking Renin-Angiotensin System Blockers
Hirai K, Morino J, Minato S, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Ookawara S, Morishita Y
Diabetes, Metabolic Syndrome and Obesity 2020, 13:215-225
Published Date: 30 January 2020
Factors Associated with Uremic Pruritus in Patients Undergoing Peritoneal Dialysis
Minato S, Hirai K, Morino J, Kaneko S, Yanai K, Mutsuyoshi Y, Ishii H, Matsuyama M, Kitano T, Shindo M, Aomatsu A, Miyazawa H, Ito K, Ueda Y, Hoshino T, Ookawara S, Morishita Y
International Journal of Nephrology and Renovascular Disease 2020, 13:1-9
Published Date: 14 January 2020
Utility Of An Automatic Limulus Amebocyte Lysate Kinetic Turbidimetric Test For Endotoxin Screening Of Dialysate Samples
Uchida T, Kaku Y, Hayasaka H, Kofuji M, Momose N, Miyazawa H, Ueda Y, Ito K, Ookawara S, Morishita Y
Medical Devices: Evidence and Research 2019, 12:429-433
Published Date: 7 October 2019
Risk factors and utility of maximum carotid intima–media thickness as a surrogate marker for coronary artery stenosis
Hirai K, Imamura S, Hirai A, Misumi K, Ookawara S, Morishita Y
Therapeutics and Clinical Risk Management 2018, 14:1407-1416
Published Date: 13 August 2018
Availability of right femoral vein as a route for tunneled hemodialysis catheterization
Shindo M, Takemae H, Kubo T, Soeno M, Ando T, Morishita Y
Medical Devices: Evidence and Research 2018, 11:233-240
Published Date: 28 June 2018
Acute hepatitis E in a renal transplantation recipient: a case report
Shindo M, Takemae H, Kubo T, Soeno M, Ando T, Morishita Y
International Medical Case Reports Journal 2018, 11:77-80
Published Date: 5 April 2018
Delivery of microRNA-146a with polyethylenimine nanoparticles inhibits renal fibrosis in vivo
Morishita Y, Imai T, Yoshizawa H, Watanabe M, Ishibashi K, Muto S, Nagata D
International Journal of Nanomedicine 2015, 10:3475-3488
Published Date: 11 May 2015
Strategies to improve physical activity by exercise training in patients with chronic kidney disease
Morishita Y, Nagata D
International Journal of Nephrology and Renovascular Disease 2015, 8:19-24
Published Date: 10 March 2015
Exercise counseling of primary care physicians in metabolic syndrome and cardiovascular diseases is associated with their specialty and exercise habits
Morishita Y, Miki A, Okada M, Tsuboi S, Ishibashi K, Ando Y, Nagata D, Kusano E
International Journal of General Medicine 2014, 7:277-283
Published Date: 17 June 2014
Association of primary care physicians' exercise habits and their age, specialty, and workplace
Morishita Y, Miki A, Okada M, Tsuboi S, Ishibashi K, Ando Y, Kusano E
Journal of Multidisciplinary Healthcare 2013, 6:409-414
Published Date: 7 November 2013
Action of irbesartan on blood pressure and glucose/lipid metabolism, in hemodialysis patients with hypertension
Onishi A, Morishita Y, Watanabe M, Numata A, Tezuka M, Okuda K, Tsunematsu S, Sugaya Y, Hashimoto S, Kusano E
International Journal of General Medicine 2013, 6:405-411
Published Date: 28 May 2013
Aliskiren suppresses the renin–angiotensin–aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension
Morishita Y, Yasui T, Numata A, Onishi A, Ishibashi K, Kusano E
International Journal of Nephrology and Renovascular Disease 2012, 5:125-133
Published Date: 21 September 2012
Long-term effects of aliskiren on blood pressure and the renin-angiotensin-aldosterone system in hypertensive hemodialysis patients
Morishita Y, Watanabe M, Hanawa S, Iimura O, Tsunematsu S, Ishibashi K, Kusano E
International Journal of Nephrology and Renovascular Disease 2012, 5:45-51
Published Date: 21 March 2012
Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis
Morishita Y, Watanabe M, Hirahara I, Akimoto T, Muto S, Kusano E
International Journal of Nephrology and Renovascular Disease 2012, 5:9-14
Published Date: 29 December 2011